Kashi Clinical Laboratories Announces Oral and Poster Presentations at ASHI 52nd Annual Meeting

Portland, OR - Kashi Clinical Laboratories (KCL), a leading provider of high complexity clinical diagnostic testing to hospitals, biopharmaceutical companies, long-term care facilities and transplant centers around the world, is pleased to announce oral and poster presentations at the 52nd Annual American Society for Histocompatibility and Immunogenetics (ASHI) Meeting in Montreal, QC, Canada October 26 - 30, 2026.

Founder and Chief Scientific Officer, Dr. Zahra Kashi, will deliver an oral presentation titled Chimeric HLA Type Detected During NMDP Donor Confirmation Typing: An Unresolvable HLA-B/C Genotype Thursday, October 29, 2026 from 5:30-5:45 PM EDT in 516ABC.

Dr. Gaurav Tripathi, HLA Director-in-Training, Laboratory Manager, and Analytics Supervisor at Kashi, will present a poster titled Integrating Copy Number Value (CNV) Analysis into High-Resolution HLA Typing for Improved Allele Assignment: From Ambiguity to Accuracy (Poster #904) during viewing and presenting times held throughout the week at the Palais des Congrès de Montréal in the Exhibit Hall. Additional authors include: Farzan Modaresi, Russ Martin, Zahra Kashi, Kashi Clinical Laboratories.

The 2026 ASHI annual meeting is expected to draw over 900 worldwide attendees who specialize in histocompatibility, immunogenetics and transplant immunology. Attendees are members and non-members of the society, industry partners, technologists, researchers and trainees who join together to share updates on immunogenetics and immunology research as well as practical guidelines in clinical histocompatibility and immunogenetics.

KCL looks forward to meeting with clients, partners, colleagues, and new connections.

About Kashi Clinical Laboratories

Kashi Clinical Laboratories (KCL) is a fully accredited clinical laboratory providing specialized solutions to academic institutions, biopharma, hospitals, long-term care facilities, and transplant centers around the world. Founded in 2006, KCL provides a full range of pre and post-transplant testing services, MMDx solid organ testing for kidney, heart, and lung, clinical pathology and genomics, and clinical trial support. KCL advances health and healing by delivering unmatched expertise, novel technologies, and exceptional service - providing diagnostics and scientific insights that empower decisions and bring hope to patients and their loved ones.

Contact
Dawn Thomas-Smith, Director of Marketing
Kashi Clinical Laboratories
[email protected]